Funding Types
At this time, Alnylam supports the following funding types:
| Educational Grants (CME) | Educational activities developed and executed by independent third parties to maintain, develop, or increase the knowledge, skills, and professional performance of an HCP | For questions about Educational Grants (CME), please contact the Alnylam Grants and Giving Office at grants@alnylam.com |
| Educational Grants (Non-CME) | Provided to a third party organization for development of an educational activity directed at providing scientific, clinical and medical information with the goal of improving patient care, or provision of a service to patients | For questions about Educational Grants (non-CME), please contact the Alnylam Grants and Giving Office at grants@alnylam.com |
| Clinical Fellowships | Funding provided to support educational clinical programs within healthcare academic organizations | For questions about Clinical Fellowships, please contact the Alnylam Grants and Giving Office at grants@alnylam.com |
| Collaborations | Activity or project undertaken by Alnylam and one or more external organization(s) that provides an opportunity for each party to contribute particular expertise or services | For questions about Collaborations, please contact the Alnylam Grants and Giving Office at grants@alnylam.com or your local Alnylam office |
| Charitable Donations | Support to registered charitable organizations to advance science, healthcare, education, or other genuine charitable purposes | For questions about charitable donations, please contact CSR@alnylam.com |
| Sponsorships | Initiatives, such as events or projects, aimed at educating patients, caregivers, scientists, or healthcare professionals where Alnylam receives a tangible benefit. | For questions about Sponsorships, please contact sponsorships@alnylam.com or your local Alnylam office |
Grants and Giving Office Process for Educational Grants
Alnylam reviews external funding applications regularly, with educational grants considered through a formal, monthly process and sponsorships, charitable donations, and collaborations on a rolling basis. Applicants should ensure that funding applications are submitted well in advance of when funding may be needed (with a minimum of 45 days). While Alnylam seeks to support the many requests we receive annually, not every request can be approved and some requests may be funded at a lower amount than what was requested.
Regardless of the outcome, Alnylam is committed to providing timely communications for each application and decisions will be shared upon completion of review. For any questions or concerns on the submission process and guidelines, please contact the Grants and Giving Office at grants@alnylam.com.
Submission
- We request that submissions are made electronically through our funding portal which is in English.
- If you have difficulty submitting your application in English, please contact our Grants and Giving office at grants@alnylam.com for further guidance.
- Funding request must be submitted at least 45 days prior to the start date of the activity or program
- Support may only be provided to eligible organizations or entities; individual recipients may not apply for nor receive funding
- Proof of tax status must be valid and government-issued.
Review
- If a request is incomplete or more information is requested, our Grants and Giving Office will contact you and ask for further information. Please try to respond with the missing information as timely as possible.
- CME and non-CME grant requests are reviewed by the Alnylam Grant Review Committee on a monthly basis (this includes applications by Patient Advocacy Organizations)
- All other types of funding are reviewed on a rolling basis.
Notification
- Funding decisions will be communicated via an email from the electronic portal
- Funding requests are not considered final until the execution of a ‘Letter of Agreement’ with Alnylam.
Reconciliation
(CME and non-CME Grants only)
(CME and non-CME Grants only)
- A reconciliation of grants must be completed within 90 days of the activity or program end date
- Any funds that are not used must be returned to Alnylam
- Failure to complete a reconciliation and/or return unused funds may jeopardize the review of future funding requests from the requesting party.
Funding Types
Fellowships
Funding provided to support educational clinical programs within healthcare academic organizations in a given area of interest. Alnylam is independent from the selection of the individual Fellow, and the educational institution requesting the funding must demonstrate that it has the infrastructure, expert faculty, curriculum, and ability to design and conduct a successful fellowship program.
Area of Educational Interest
A Clinical Fellowship Grant is intended to support clinical fellowship programs that mentor and advance the training of physicians in the diagnosis, treatment, and research of Transthyretin (ATTR) Amyloidosis. The program will foster multidisciplinary collaboration to improve early recognition, optimize treatment pathways, and accelerate the translation of emerging science into high-quality, patient-centered care.
The US Clinical Fellowship Program for academic year 2027-2028 is closed and no longer accepting applications. Details on the US Clinical Fellowship Program for academic year 2028-2029 will be posted in spring of 2027.
Continuing Medical Education Grants (CME)
These are educational activities developed and executed by independent third party organizations to maintain, develop, or increase the knowledge, skills, and professional performance that a healthcare professional uses to provide services for patients, the public, or the profession. A CME grant is an unsolicited funding request that may be accredited or non-accredited. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit. Examples might include a live program at a medical conference or an online educational session for CME credit.
Educational Grants (non-CME)
This is funding that is provided in response to an unsolicited request from an eligible third-party organization that has independently applied for grant support for accredited or unaccredited medical education activities or education directed to HCPs, patient organizations, patients, or other members of the health care community. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit. Examples of a non-CME Educational Grant might include educational videos or newsletters.
Responses to Requests for Proposals
Throughout the year, Alnylam will post Request for Proposals (RFP) to inform organizations and qualified medical education providers that we are interested in receiving requests for independent medical education activities pertinent to Alnylam’s areas of interest and aligned to specifications outlined in our RFPs. The grantee is responsible for the design and execution of the initiative supported by the grant, including compliance with any regulatory requirements. Alnylam may not receive any tangible business benefit. Transparency of Alnylam’s support is required and is not considered a tangible benefit.
Disease Areas Of Interest
Transthyretin-mediated Amyloidosis (ATTR amyloidosis)
Acute Hepatic Porphyria (AHP)
Primary Hyperoxaluria Type 1 (PH1)
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site